Counter Cyclical Investment crosses 5% stake in Jenburkt Pharma

Counter Cyclical Investment Private Limited, acting as a Portfolio Manager, has disclosed an increase in its shareholding in Jenburkt Pharmaceuticals Ltd. As of October 9, 2026, the acquirer, on behalf of its clients, held 220,605 shares, representing 4.99% of the total paid-up share capital. Following an acquisition of 326 additional shares on the same date, the total holding has reached 220,931 shares, amounting to 5.01% of the total paid-up share capital. This disclosure is made in compliance with Regulation 29(1) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, requiring disclosure upon crossing the 5% threshold.